bluebird bio (BLUE) May Offer The Most Hope To Sickle Cell Patients...A Cure - Maxim Sep 22, 2016 07:46AM
Streetinsider.com's Hot Lunchtime Reads 9/21: (LL) (RHT) (CUR) (TSLA) Sep 21, 2016 12:13PM
Maxim Group Downgrades Mast Therapeutics (MSTX) to Hold Following Vepoloxamer Phase 3 Miss Sep 21, 2016 12:03PM
Mast Therapeutics (MSTX) Could Heat Up as Data Rolls in this Summer - Maxim Group Jul 12, 2016 01:48PM
Mast Theraputics (MSTX): Building IP to Treat Sickle Cell Pain Crisis - Maxim Group Jun 9, 2016 09:31AM


Feb 16, 2016 04:15PM Mast Therapeutics Closes $8 Million Public Offering
Feb 10, 2016 09:24AM Mast Therapeutics (MSTX) Prices 29M Offering of Common Stock and Warrants at $0.275/Unit
Feb 10, 2016 09:09AM Mast Therapeutics Announces Pricing Of Underwritten Public Offering
Jan 7, 2016 12:22PM Streetinsider.com's Hot Lunchtime Reads 1/7: (TSLA) (GSI) (NFLX) (ADTN)
Jan 7, 2016 12:01PM Maxim Group Reiterates $5 Price Target on Mast Therapeutics (MSTX)
Nov 12, 2015 10:49AM Notable Analyst Rating Changes 11/12: (M) (GALE) (DVN) Upgraded; (SUNE) (BSBR) (PWR) Downgraded
Nov 12, 2015 09:33AM Pre-Open Stock Movers 11/12: (ANGI) (NTES) (GALE) Higher; (DSCI) (DGLY) (FRPT) Lower (more...)
Nov 11, 2015 04:50PM Maxim Group Starts Mast Therapeutics (MSTX) at Buy